LES Toronto Chapter & LSS Webinar: Pharma-Biotech Product & Company Valuation

Details:
 
Valuation is a key factor for any biotech and pharma company. Learn how to calculate and determine the right assumption for any therapeutic product (pre-clinical, clinical or on the market) to structure a suitable licensing deal and understand how to assess biotech company for financing rounds and M&A. 
 
Why you should attend:
Whether you raise money, try to out or in-license products as a business development executive or you would like just a basic understanding of how valuation works, this is the ideal introduction for you.
 
The content: 
Valuation in Life Sciences is probably one of the most difficult tasks. What deal terms can you ask for or what should be the equity share to a new investor? These are critical question for most life sciences companies. However, valuation is more than just numbers – it’s about the assumptions and about understanding the business, so it comes down to the potential of a product or company and the associated risk.
 
 
The expert: 
Patrik has worked for over 20 years in the field of biotechnology and product valuations, having Novartis Venture Fund as his first client. With over 700 valuations around the world, multiple publications and top-tier clients, Patrik is the leading expert. 
 
 
Who should attend?
Anybody active in the life sciences industry and involved in fundraising, licensing, technology transfer and business development. Both people with either a pure finance or a scientific background can benefit from this introduction.

Members: Free

Nonmembers: $69